Denali officer plans sale of 2,768 shares

Denali Therapeutics Inc. (DNLI) is the issuer for a planned sale of common stock reported under Rule 144 on behalf of officer Alexander Schuth.

Rhea-AI Filing Summary

Denali Therapeutics Inc. (DNLI) is the issuer for a planned sale of common stock reported under Rule 144 on behalf of officer Alexander Schuth. The notice covers 2,768 shares of common stock to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with an approximate aggregate market value of $65,767.68 as referenced. The shares relate to Restricted Stock Units with an acquisition date of 08/09/2026, and the proposed sale date is 09/01/2026 on NASDAQ.

Key Figures

Shares to be sold: 2,768 shares of common stock Approximate aggregate market value: $65,767.68 CUSIP/identifier: 55934378 +2 more

5 metrics

Shares to be sold 2,768 shares of common stock Planned sale under Rule 144 by officer Alexander Schuth

Approximate aggregate market value $65,767.68 Referenced for the 2,768 shares covered by the Form 144

CUSIP/identifier 55934378 Numeric identifier associated with the common stock entry

Proposed sale date 09/01/2026 Date for sale of common shares on NASDAQ

Acquisition date of RSUs 08/09/2026 Acquisition date for Restricted Stock Units related to the shares

Key Terms

Rule 144, Restricted Stock Units, Form 144, NASDAQ

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Common | 08/09/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

NASDAQ market

"09/01/2026 | NASDAQ"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing involving DNLI disclose?

It discloses that officer Alexander Schuth has filed a Rule 144 notice for a proposed sale of 2,768 shares of Denali Therapeutics Inc. common stock, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on or about 09/01/2026.

How many DNLI shares are covered by Alexander Schuth’s Form 144?

The Form 144 notice covers 2,768 shares of Denali Therapeutics Inc. common stock. These shares are associated with Restricted Stock Units with an acquisition date of 08/09/2026.

What is the approximate value of the DNLI shares in this Form 144?

The filing references an approximate aggregate market value of $65,767.68 for the 2,768 shares of Denali Therapeutics Inc. common stock covered by the Rule 144 notice.

When are the DNLI shares expected to be sold under this Form 144?

The proposed sale date stated in the Form 144 is 09/01/2026. The shares are to be sold on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services.

What type of DNLI securities are involved in this Form 144 filing?

The securities are common stock of Denali Therapeutics Inc., tied to Restricted Stock Units with an acquisition date of 08/09/2026, for which a proposed sale of 2,768 shares has been noticed under Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 04:48 PM EDT Accepted by SEC EDGAR 09/01/2026 - 04:47 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001724311
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	DENALI THERAPEUTICS INC
SEC File Number	001-38311
Address of Issuer	161 Oyster Point Blvd. South San Francisco CALIFORNIA 94080
Phone	6508668548
Name of Person for Whose Account the Securities are To Be Sold	ALEXANDER SCHUTH
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2768	65767.68	55934378	09/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/09/2026	Restricted Stock Units	Issuer			2768	08/09/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/27/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Alexander Schuth
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)